By C SIMPSON
Vaccine experts who advise the US government said yesterday that FluMist, the nasal flu vaccine used by millions, should not be administered this coming flu season, since it hasn’t worked over the past three flu seasons. The vaccine is made by AstraZeneca, which in response said it would take an $80 million writedown on its supply of FluMist.
Leave a Reply